ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Non-Small-Cell Lung Cancer trials near San Francisco, CA, USA:

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

with stage I-IIIA Epithelial Growth Factor Receptor (EGFR) -mutant non-small cell lung cancer before sur ...

Active, not recruiting
Stage IA Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Drug: Osimertinib
Procedure: Therapeutic Conventional Surgery

Phase 2

University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 2 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 137 other locations

This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small ...

Active, not recruiting
Non-small Cell Lung Cancer (NSCLC)
Cancer
Drug: Cofetuzumab Pelidotin

Phase 1

AbbVie
AbbVie

Stanford, California, United States and 25 other locations

body radiation therapy (SBRT) in treating patients with stage I non-small cell lung cancer that cannot b...

Active, not recruiting
Stage I Non-Small Cell Lung Cancer
Radiation: Stereotactic Body Radiation Therapy
Drug: Atezolizumab

Phase 1

Megan Daly, MD

Travis Air Force Base, California, United States and 1 other location

of AZD9291 versus a standard of care epidermal growth factor receptor tyrosine kinase inhibitor in patients with locally advanced or Metastatic Non...

Active, not recruiting
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
Drug: Erlotinib 150/100 mg
Drug: Placebo Erlotinib 150/100mg

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 168 other locations

This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...

Active, not recruiting
Advanced Non Small Cell Lung Cancer
Metastatic Non Small Cell Lung Cancer
Drug: Docetaxel
Drug: MRTX849

Phase 3

Mirati Therapeutics
Mirati Therapeutics

Santa Rosa, California, United States and 227 other locations

This is a pilot study using [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with ad...

Enrolling
Non Small Cell Lung Cancer
Drug: [18F]F AraG

Phase 2

CellSight Technologies

Palo Alto, California, United States and 2 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Santa Rosa, California, United States and 152 other locations

in combination with pembrolizumab in participants with advanced non-small cell lung cancer (NSCLC) or ho....

Active, not recruiting
Breast Cancer
Non Small Cell Lung Cancer
Drug: Abemaciclib
Drug: Pembrolizumab

Phase 1

Lilly
Lilly

San Francisco, California, United States and 23 other locations

, early-stage non-small cell lung cancer....

Enrolling
Non-small Cell Lung Cancer
Drug: Cisplatin
Drug: Oleclumab

Phase 2

AstraZeneca
AstraZeneca

Oakland, California, United States and 94 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems